# Synthesis and Antifungal Studies of (2E)-N-Benzyl-N′-phenylbut-2-enediamide and (2E)-N,N′-Dibenzylbut-2-enediamide Analogues

Authors: Habila J. Dama; Kandappa H. Reddy; Patrick Govender; Neil A. Koorbanally
Journal: Journal of Chemistry
 (2013)

---

## Abstract

A series of eleven butanediamine analogues, of which nine were new, were synthesized by the nucleophilic substitution of aromatic amines and benzylamines with maleic anhydride and tested on four yeast strains ofCandida species using the broth microdilution method. Compounds 3a and 3c with an unsubstituted phenyl ring and a 3-methoxyphenyl ring, respectively, are the most active against the fungal species with MIC values ranging from 20.2 to 80.6 μM for C. albicans and C. parapsilosis and 178.5 and 161.2 μM for C. krusei, respectively.


---

## Body

## 1. Introduction

Molecules having an amide functionality have played a significant role in medicine and pharmacology, being used as anticancer agents [1–4], antiproliferative agents [5], for inflammation [6], Parkinson’s disease [7], and as antimicrobial agents [8, 9], antioxidants [10],  and anti-HIV agents [11, 12].  The HIV epidemic has led to an increase in the number of immunocompromised patients, which in turn has resulted in an increase in the number of systemic fungal infections.  Due to this, recent research has started to focus on new potential antifungal agents [13–20]. Clinical therapy has relied mainly on the use of either amphotericin B (ergosterol-binding polyene) or azole (lanosterol demethylase inhibitors) antifungal agents [21].  Resistance to these drugs necessitates the need for the synthesis of new antifungal drugs.  This prompted us to investigate the potential of the butanediamines to act as possible antifungal agents.Some of the synthetic approaches to synthesising these amides include the Aza-Michael addition of an amine toN-phenylmaleimide using trans-N,N,N′,N′-tetramethylcyclohexanediamine (TMCDA) as a receptor  [22], cross-metathesis of acrylic amide with NHC Grubbs ruthenium catalyst [23], and the use of DCC, either with 1-hydroxybenzotriazole (HOBT) or but-2-en-1,4-dioic acid and benzylamine [24], which we have chosen to adopt with some modification along with the modified method of esterification of carboxylic acids, in which we have formed amides rather than the esters by using amines instead of alcohols [25].To the best of our knowledge, no biological studies of these compounds have been reported and only the syntheses of3a [22] and 3i [23] have been reported.  We present here the synthesis of several butanediamine analogues with different electron donating and withdrawing groups (OCH3,NO2,Cl,F) and explored their potential to act as antifungal agents.


## 2. Materials and Methods

### 2.1. General Experimental Details

All chemicals were reagent grade and purchased from Sigma-Aldrich (Germany) through Capital Laboratories (South Africa).  Analytical thin layer chromatography (TLC) was performed using precoated silica gel 60(F254) from MERCK (South Africa).  Visualization was achieved by UV light (254 nm) and by heating with 20%  H2SO4 acid in MeOH. NMR spectra were recorded using a BrukerAvanceIII 400 MHz spectrometer at room temperature in DMSO-d6 with chemical shifts (δ) recorded against the internal standard, tetramethylsilane (TMS).  The infrared spectra of the solid samples were recorded on a Perkin Elmer Spectrum 100 FTIR spectrometer with universal ATR sampling accessory. The gas chromatography mass spectrometry (GC-MS) was carried out by the electron impact ionization method, using an Agilent GC-MSD apparatus equipped with a DB-5SIL MS fused-silica capillary column. UV/Vis analysis was carried out on a Perkin Elmer Lambda 35 UV/VIS spectrometer with a scan range of 200–400 nm. Melting point determination was carried out on an Ernst Leitz Wetzlar number 461086 microhot stage melting point apparatus. High resolution mass spectrometry (HRMS) was recorded on a waters Q-TOF Micromass spectrometer with a lock spray source.


### 2.2. Synthesis of the Intermediate Carboxylic Acids(2a–k)

Maleic anhydride (2.8 g, 28 mmol) was weighed into a round bottom flask containing 20 mL of toluene. The substituted anilines (1a–g), 3-aminopyridine (1h) or substituted benzylamines (1i–k) (25 mmol) were then added to the mixture, which was then stirred under reflux for 2 h.  The heat was then removed and the reaction stirred for a further 30 min. The solid carboxylic acid intermediates 2a (48% yield), 2b (36%), 2c (74%), 2d (42%), 2e (51%), 2f (42%), 2g (34%), 2h (47%), 2i (45%), 2j (64%), and 2k (65%) were obtained after being filtered under suction and washed with toluene.  Compounds 2a–k were all known, and their structures were confirmed by comparing their spectroscopic and physical data with that in the literature [26–30].


### 2.3.  Synthesis of the But-2-enediamides(3a–k)

To a solution of  the substituted acids(2a–k) (2.3 mmol) and diisopropylcarbodiimide (DIC, 0.32 g; 2.5 mmol) in DMF (7 mL), dimethylaminopyridine (DMAP, 0.08 g; 0.65 mmol) was added and the mixture stirred at room temperature for at least 30 min. Benzylamine (0.27 g; 2.5 mmol) was then added and the reaction mixture stirred at room temperature under nitrogen for 12 hrs. A volume of 10 mL of dichloromethane (DCM) was then introduced and the contents stirred for a further 5 min and then washed with brine (3×10mL), separated, and dried on MgSO4. A precipitate was observed upon cooling the organic layer on ice, which was filtered under suction and washed with DCM, producing the products (3a–k) in pure form.Compounds3a and 3i were synthesised previously [22, 23]; however NMR data for 3a are not reported in Bi et al. [22] and are therefore presented below.  The 1H and 13C NMR data for 3i (32% yield) was consistent with that reported in Streuff and Muñiz [23].(2E)-N-Benzyl-
N
′
-phenylbut-2-enediamide(3a).
White powder (35% yield); mp 265–267°C; UV λmax (CH3OH) nm (log ε) 290 (4.31); IR  (KBr) υmax (cm−1) 3266 (NH), 3061, 1633 (C=O), 1598, 1542; 1H NMR (DMSO-d6, 400 MHz) δ 10.47 (s, 1H, NH-5), 9.01 (bt, 1H, J=5.9Hz, NH-6), 7.68 (d, 2H, J=8.1Hz, H-2′/6′), 7.34–7.36 (m, 4H,  H-3′/5′, H-3′′/5′′), 7.28–7.33 (m, 3H, H-2′′/6′′, H-4′′), 7.10–7.12 (m, 1H,  H-4′),  7.11 (d, 1H, J=15.1Hz, H-3), 7.04 (d, 1H, J=15.1Hz, H-2), 4.41 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 162.7 (C-4), 139.4 (C-1′′), 139.3 (C-1′), 134.1 (C-2), 133.7 (C-3), 129.3 (C-3′/5′), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 124.3 (C-4′), 119.8 (C-2′/6′), 42.9 (C-7′′).(2E)-N-Benzyl-
N
′
-(2-methoxyphenyl)but-2-enediamide(3b).
White powder (18% yield); mp 260–262°C; UV λmax (CH3OH) nm (log ε) 310 (4.76), 275 (4.92), 240 (5.23); IR  (KBr) υmax (cm−1) 3271 (NH), 3034, 1626 (C=O), 1537, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 9.73 (s, 1H, NH-5), 8.95 (bt, 1H, J=5.6Hz, NH-6), 8.01 (d, 1H, J=7.7Hz, H-6′), 7.35 (d, 1H,  J=15.1Hz, H-3), 7.33–7.35 (m, 2H, H-3′′/5′′), 7.28–7.30 (m, 3H, H-2′′/6′′, H-4′′), 7.11 (m, 1H, H-5),  7.01 (d, 1H, J=15.1Hz, H-2), 7.00 (d, 1H, J=7.7Hz, H-3′), 6.92 (t, 1H,  J=7.7Hz, H-4′), 4.40 (d, 2H, J=5.6Hz, H-7′′), 3.83 (s, 3H, 2′-OCH3); 13C NMR (DMSO-d6, 100 MHz) δ 164.2 (C-1), 163.0 (C-4), 150.5 (C-2′), 139.4 (C-1′′), 134.1 (C-2), 134.0 (C-3), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 125.5 (C-5′), 122.8 (C-6′), 120.67 (C-4′), 111.8 (C-3′), 56.15 (2′-OCH3), 42.85 (C-7′′); EIMS (m/z) 310 [M+], 281, 249, 207, 188, 160, 106, 91; HRMS (m/z): 310.1318 (calculated for C18H18N2O3, 310.1315).(2E)-N-Benzyl-
N
′
-(3-methoxyphenyl)but-2-enediamide(3c).
White powder (65% yield); mp 240-241°C; UV λmax (CH3OH) nm (log ε) 310 (3.88), 280 (3.88), 240 (4.04); IR (KBr) υmax (cm−1)  3266 (NH), 3070, 1633 (C=O), 1602 (NH), 1544, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 10.45 (s, 1H, NH-5), 9.02 (bt, 1H, J=5.8Hz, NH-6), 7.38 (s, 1H, H-2′), 7.33–7.35 (m, 2H, H-3′′/H-5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.19–7.23 (m, 2H, H-5′,6′), 7.08 (d, 1H, J=15.1Hz, H-2), 7.02 (d, 1H, J=15.1Hz, H-3), 6.69 (d, 1H,  J=7.8Hz, H-4′), 4.40 (d, 2H, J=5.8Hz, H-7′′), 3.73 (s, 3H, 3′-OCH3); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 162.7 (C-4), 160.0 (C-3′), 140.4 (C-1′), 139.3 (C-1′′), 134.2 (C-2), 133.7 (C-3), 130.1 (C-5′), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.5 (C-4′′), 112.2 (C-6′), 109.7 (C-4′), 105.7 (C-2′), 55.5 (3′-OCH3), 42.9 (C-7′′). EIMS (m/z): 310 [M+], 281, 207, 187, 176, 149, 106, 91; HRMS (m/z):  310.1315 (calculated for C18H18N2O3, 310.1315).(2E)-N-Benzyl-
N
′
-(2-chlorophenyl)but-2-enediamide(3d).
Pale brown powder (24% yield); mp 244-245°C; UV λmax (CH3OH) nm (log ε) 275 (4.36); IR (KBr) υmax (cm−1)  3267 (NH), 3032, 1626 (C=O), 1531, 1494; 1H NMR (DMSO-d6, 400 MHz) δ 10.08 (s, 1H, NH-5), 9.00 (bt, 1H, J=5.9Hz, NH-6), 7.79 (d, 1H, J=7.9Hz, H-6′),  7.53 (d, 1H,  J=7.9Hz, H-3′), 7.32–7.35 (m, 2H, H-3′′/5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.07 (d, 2H, J=15.2Hz, H-2/3), 4.42 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 163.1 (C-4), 139.3 (C-1′′), 134.9  (C-2), 134.8 (C-3), 133.1 (C-4′), 130.1 (C-3′), 128.9 (C-3′′/5′′), 127.9 (C-4′′), 127.8 (C-2′′/6′′), 127.4 (C-5′), 126.9 (C-6′), 42.9 (C-7′′); EIMS (m/z): 314 [M+], 281, 207, 187, 138, 106; HRMS (m/z):  314.0820 (calculated for C17H15ClN2O2, 314.0820).(2E)-N-Benzyl-
N
′
-(3-chlorophenyl)but-2-enediamide(3e).
Pink powder (30% yield); mp 272–274°C; UV λmax (CH3OH) nm (log ε) 290 (4.66), 240 (4.60); IR (KBr) υmax (cm−1) 3265 (NH), 3066, 1633 (C=O), 1592, 1541, 1482; 1H NMR (DMSO-d6, 400 MHz) δ 10.63 (s, 1H, NH-5), 9.03 (bt, 1H, J=5.9Hz, NH-6), 7.92 (s, 1H, H-2′), 7.51 (d, 1H,  J=8.5Hz, H-4′), 7.36–7.38 (m, 1H, H-5), 7.32–7.34 (m, 2H, H-3′′/5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.17 (d, 1H, J=8.5Hz, H-6′), 7.06 (s, 2H, H-2/3), 4.41 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.4 (C-1), 162.5 (C-4), 140.2 (C-1′), 138.8 (C-1′′), 134.2 (C-2), 133.1 (C-3), 132.7 (C-3′), 130.5 (C-5′), 128.4 (C-3′′/5′′), 127.3 (C-2′′/6′′), 126.9 (C-4′′),  123.5 (C-6′), 118.8 (C-2′), 117.8 (C-4′), 42.4 (C-7′′). EIMS (m/z) 314 [M+], 281, 207, 180, 153, 138, 117, 106, 91; HRMS (m/z):  314.0826 (calculated for C17H15ClN2O2,   314.0820).(2E)-N-Benzyl-
N
′
-(3-nitrophenyl)but-2-enediamide(3f).
Cream powder (29% yield); mp 259–261°C; UV λmax (CH3OH) nm (log ε) 275 (5.21); IR (KBr) υmax (cm−1) 3271 (NH), 3038, 1643 (C=O), 1621, 1529; 1H NMR (DMSO-d6, 400 MHz) δ 10.95 (s, 1H, NH-5), 9.07 (bt, 1H, J=5.3Hz, NH-6), 8.74 (s, 1H, H-2′), 7.97 (d, 2H, J=7.8Hz, H-4′/6′), 7.67 (t, 1H, J=7.8Hz, H-5′), 7.33–7.35 (m, 2H, H-3′′/5′′), 7.26–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.10 (s, 2H, H-2/3), 4.43 (d, 2H, J=5.3Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.8 (C-1), 163.4 (C-4), 148.5 (C-3′), 140.4 (C-1′), 139.3 (C-1′′), 135.0 (C-2), 133.0 (C-3), 130.8 (C-5′), 128.9 (C-3′′/5′′), 127.9 (C-2′′/6′′), 127.5 (C-4′′), 125.8 (C-6′), 118.9 (C-4′), 113.9 (C-2′), 42.9 (C-7′′). EIMS (m/z): 325 [M+], 280, 234, 191, 164, 149, 117, 91; HRMS (m/z):  325.1057 (calculated for C18H18N2O3, 325.1060).(2E)-N-Benzyl-
N
′
-(4-nitrophenyl)but-2-enediamide(3g).
Pale brown powder (12% yield); mp 274–276°C; UV λmax (CH3OH) nm (log ε) 325 (4.90); IR  (KBr) υmax (cm−1) 3267 (NH), 3062, 1626 (C=O), 1534, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 11.05 (s, 1H, NH-5), 9.07 (bt, 1H, J=5.9Hz, NH-6), 8.26 (d, 2H, J=9.1Hz, H-3′′/5′′), 7.92 (d, 2H,  J=9.1Hz, H-2′′/6′′), 7.29–7.35 (m, 2H, H-3′′/5′′), 7.25–7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.11 (s, 2H, H-2,3), 4.42 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.6 (C-1), 163.3 (C-4), 145.2 (C-1′), 142.9 (C-4′), 139.0 (C-1′′), 135.2 (C-2), 132.7 (C-3), 128.6 (C-3′′/5′′), 127.7 (C-2′′/6′′), 127.3  (C-4′′), 125.3 (C-3′/5′), 119.5 (C-2′/6′), 42.8 (C-7′′); EIMS (m/z): 325, 281, 249, 207, 187, 167, 149, 106; HRMS (m/z):  325.1059 (calculated for C17H15N3O4, 325.1060).(2E)-N-Benzyl-
N
′
-(pyridin-3-yl)but-2-enediamide(3h).
Brown powder (27% yield); mp 198–200°C; UV λmax (CH3OH) nm (log ε) 270 (4.64), 240 (4.75); IR (KBr) υmax (cm−1) 3268 (NH), 3061, 1625 (C=O), 1532 (NH), 1493; 1H NMR (DMSO-d6, 600 MHz) δ 10.69 (s, 1H, NH-5), 9.04 (bt, 1H, J=5.6Hz, NH-6), 8.81 (s, 1H, H-2′), 8.31 (d, 1H, J=8.2Hz, H-6′), 8.14 (d, 1H, J=8.2Hz, H-4′), 7.38-7.39 (m, H-5′), 7.34–7.36 (m, 2H, H-3′′/5′′), 7.26–7.30 (m, 3H, H-2′′/6′′, H-4′′), 7.10 (d, 1H, J=15.1Hz, H-3), 7.07 (d, 1H, J=15.1Hz, H-2), 4.42 (d, 2H, J=5.6Hz, H-7′′); 13C NMR (DMSO-d6, 150 MHz) δ 163.9 (C-1), 163.2 (C-4), 145.2 (C-6′), 141.4 (C-2′), 139.3 (C-3′), 136.0 (C-1′′), 134.7 (C-2), 133.0 (C-3), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.5 (C-4′′), 126.8 (C-4′), 124.2 (C-5′),  42.9 (C-7′′). EIMS (m/z) 281 [M+], 207, 187, 147, 119, 106, 91; a high resolution mass could not be detected for this compound despite several attempts.(2E)-N-Benzyl-
N
′
-(3-fluorobenzyl)but-2-enediamide(3j).
White powder (45% yield); mp 298–300°C; UV λmax (CH3OH) nm (log ε) 250 (4.08); IR (KBr) υmax (cm−1) 3275 (NH), 3085, 1626 (C=O), 1591, 1555; 1H NMR (DMSO-d6, 400 MHz) δ 8.94 (t, 1H, J=5.9Hz, NH-5), 8.93 (t, 1H, J=5.9Hz, NH-6), 7.30–7.36 (m, 3H, H-5′, H-3′′/5′′), 7.25–7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.05–7.11 (m, 3H, H-2′,4′,6′), 6.93 (s, 2H, H-2/3), 4.39 (d, 2H, J=5.9Hz, H-7′), 4.37 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.8 (C-4), 163.6 (C-1), 162.2 (d, JCF=242.0Hz, C-3′), 141.9 (d, JCF=7.2Hz, C-1′), 138.9 (C-1′′), 132.9 (C-2), 132.6 (C-3),  130.3 (d, JCF=8.4Hz, C-5′), 128.3 (C-3′′/5′′), 127.3 (C-2′′/6′′), 126.9 (C-4′′), 123.2 (d, JCF=2.7Hz, C-6′),  113.9 (d, JCF=21.3Hz, C-2′), 113.6 (d, JCF=20.9Hz, C-4′), 42.3 (C-7′), 41.8 (C-7′′); 19F-NMR (DMSO-d6, 376.5 MHz) δ  −113.46, HRMS (m/z):  312.1270 (calculated for C18H17N2O2F, 312.1272).(2E)-N-Benzyl-
N
′
-(4-fluorobenzyl)but-2-enediamide(3k).
Pink powder (50% yield); mp 299–301°C; UV λmax (CH3OH) nm (log ε) 250 (4.50); IR (KBr) υmax (cm−1) 3275 (NH), 3084, 1624 (C=O), 1539, 1487; 1H NMR (DMSO-d6, 400 MHz) δ 8.97 (bs, 1H, NH-5), 8.93 (bs, 1H, NH-6), 7.36–7.38 (m, 2H, H-3′′/5′′), 7.31-7.32 (m, 2H, H-2′/6′), 7.26-7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.09–7.11 (m, 2H, H-3′/5′), 6.93 (s, 2H, H-2/3), 4.38 (bs,  4H, H-7′/7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.2 (C-1), 164.1 (C-4), 161.6 (d, JCF=252.5Hz, C-4′), 139.4 (C-1′), 135.7 (C-1′′), 133.3 (C-2), 133.2 (C-3), 129.8 (d,  JCF=8.0Hz, C-2′/6′), 128.8 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 115.6  (d, JCF=20.9Hz, C-3′/5′), 42.8 (C-7′), 42.1 (C-7′′); 19F-NMR (DMSO-d6, 376.5 MHz) δ −116.0, HRMS (m/z): 312.1271 (calculated for C18H17FN2O2, 312.1272).


### 2.4. Biological Assay

Microbial Strains. The test compounds were evaluated on American Type Culture Collection (ATCC) strains of four Candida yeasts, Candida albicans (90028), Candida albicans (10231), Candida krusei (6258), and Candida parapsilosis (22019). Yeast strains were grown on sabouraud dextrose agar (SDA) and incubated at 35°C for 24 h.Antifungal Agents. The test compounds were dissolved in DMSO and made to a final concentration of 2% DMSO in each well.  All dilutions were done just prior to carrying out the assays. The final concentration of the test compounds ranged from 3.8 nM to 715.0 µM.  All drug dilutions were carried out in 96-well flat bottom microtitre plates. Amphotericin-B from Sigma Aldrich was used as a reference drug for the antifungal assay.Antifungal Susceptibility Test. Evaluation of the susceptibility of Candida albicans and non-Candida albicans species as performed using the broth microdilution method according to M27-A2 for yeast guidelines [31]. Yeast strains were grown aerobically overnight at 35°C on SDA plates. Yeasts were harvested and suspended in 1% sterile saline, and the turbidity of the supernatants measured spectrophotometrically at 625 nm with an absorbance of 0.08–0.1 is equivalent to a 0.5 McFarland standard following the NCCLS M27-A2 guidelines. The working suspension was diluted 20 times in a mixture containing RPMI 1640 medium and 0.165 M morpholinepropanesulfonic acid buffered to a pH of  7.0. The working suspension was further diluted 50 times to obtain the final test inoculums (1-5×103CFUmL-1). The microtitre plates that contained different concentrations of the test compounds were allowed to thaw and equilibrate to room temperature under aseptic conditions.  Aliquots of working inoculum suspensions were dispensed into each well, and the plates incubated in an aerobic environment at 35°C for 24 h. After incubation, 20 µL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS, Promega Corporation, Madison, USA) was added directly to  each well, incubated at 37°C for 4 h and the absorbance recorded at 490 nm on a 96-well plate reader (VACUTEC). All analyses were performed in triplicate, and data are reported as the mean ± standard error of the mean of ≤5.


## 2.1. General Experimental Details

All chemicals were reagent grade and purchased from Sigma-Aldrich (Germany) through Capital Laboratories (South Africa).  Analytical thin layer chromatography (TLC) was performed using precoated silica gel 60(F254) from MERCK (South Africa).  Visualization was achieved by UV light (254 nm) and by heating with 20%  H2SO4 acid in MeOH. NMR spectra were recorded using a BrukerAvanceIII 400 MHz spectrometer at room temperature in DMSO-d6 with chemical shifts (δ) recorded against the internal standard, tetramethylsilane (TMS).  The infrared spectra of the solid samples were recorded on a Perkin Elmer Spectrum 100 FTIR spectrometer with universal ATR sampling accessory. The gas chromatography mass spectrometry (GC-MS) was carried out by the electron impact ionization method, using an Agilent GC-MSD apparatus equipped with a DB-5SIL MS fused-silica capillary column. UV/Vis analysis was carried out on a Perkin Elmer Lambda 35 UV/VIS spectrometer with a scan range of 200–400 nm. Melting point determination was carried out on an Ernst Leitz Wetzlar number 461086 microhot stage melting point apparatus. High resolution mass spectrometry (HRMS) was recorded on a waters Q-TOF Micromass spectrometer with a lock spray source.


## 2.2. Synthesis of the Intermediate Carboxylic Acids(2a–k)

Maleic anhydride (2.8 g, 28 mmol) was weighed into a round bottom flask containing 20 mL of toluene. The substituted anilines (1a–g), 3-aminopyridine (1h) or substituted benzylamines (1i–k) (25 mmol) were then added to the mixture, which was then stirred under reflux for 2 h.  The heat was then removed and the reaction stirred for a further 30 min. The solid carboxylic acid intermediates 2a (48% yield), 2b (36%), 2c (74%), 2d (42%), 2e (51%), 2f (42%), 2g (34%), 2h (47%), 2i (45%), 2j (64%), and 2k (65%) were obtained after being filtered under suction and washed with toluene.  Compounds 2a–k were all known, and their structures were confirmed by comparing their spectroscopic and physical data with that in the literature [26–30].


## 2.3.  Synthesis of the But-2-enediamides(3a–k)

To a solution of  the substituted acids(2a–k) (2.3 mmol) and diisopropylcarbodiimide (DIC, 0.32 g; 2.5 mmol) in DMF (7 mL), dimethylaminopyridine (DMAP, 0.08 g; 0.65 mmol) was added and the mixture stirred at room temperature for at least 30 min. Benzylamine (0.27 g; 2.5 mmol) was then added and the reaction mixture stirred at room temperature under nitrogen for 12 hrs. A volume of 10 mL of dichloromethane (DCM) was then introduced and the contents stirred for a further 5 min and then washed with brine (3×10mL), separated, and dried on MgSO4. A precipitate was observed upon cooling the organic layer on ice, which was filtered under suction and washed with DCM, producing the products (3a–k) in pure form.Compounds3a and 3i were synthesised previously [22, 23]; however NMR data for 3a are not reported in Bi et al. [22] and are therefore presented below.  The 1H and 13C NMR data for 3i (32% yield) was consistent with that reported in Streuff and Muñiz [23].(2E)-N-Benzyl-
N
′
-phenylbut-2-enediamide(3a).
White powder (35% yield); mp 265–267°C; UV λmax (CH3OH) nm (log ε) 290 (4.31); IR  (KBr) υmax (cm−1) 3266 (NH), 3061, 1633 (C=O), 1598, 1542; 1H NMR (DMSO-d6, 400 MHz) δ 10.47 (s, 1H, NH-5), 9.01 (bt, 1H, J=5.9Hz, NH-6), 7.68 (d, 2H, J=8.1Hz, H-2′/6′), 7.34–7.36 (m, 4H,  H-3′/5′, H-3′′/5′′), 7.28–7.33 (m, 3H, H-2′′/6′′, H-4′′), 7.10–7.12 (m, 1H,  H-4′),  7.11 (d, 1H, J=15.1Hz, H-3), 7.04 (d, 1H, J=15.1Hz, H-2), 4.41 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 162.7 (C-4), 139.4 (C-1′′), 139.3 (C-1′), 134.1 (C-2), 133.7 (C-3), 129.3 (C-3′/5′), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 124.3 (C-4′), 119.8 (C-2′/6′), 42.9 (C-7′′).(2E)-N-Benzyl-
N
′
-(2-methoxyphenyl)but-2-enediamide(3b).
White powder (18% yield); mp 260–262°C; UV λmax (CH3OH) nm (log ε) 310 (4.76), 275 (4.92), 240 (5.23); IR  (KBr) υmax (cm−1) 3271 (NH), 3034, 1626 (C=O), 1537, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 9.73 (s, 1H, NH-5), 8.95 (bt, 1H, J=5.6Hz, NH-6), 8.01 (d, 1H, J=7.7Hz, H-6′), 7.35 (d, 1H,  J=15.1Hz, H-3), 7.33–7.35 (m, 2H, H-3′′/5′′), 7.28–7.30 (m, 3H, H-2′′/6′′, H-4′′), 7.11 (m, 1H, H-5),  7.01 (d, 1H, J=15.1Hz, H-2), 7.00 (d, 1H, J=7.7Hz, H-3′), 6.92 (t, 1H,  J=7.7Hz, H-4′), 4.40 (d, 2H, J=5.6Hz, H-7′′), 3.83 (s, 3H, 2′-OCH3); 13C NMR (DMSO-d6, 100 MHz) δ 164.2 (C-1), 163.0 (C-4), 150.5 (C-2′), 139.4 (C-1′′), 134.1 (C-2), 134.0 (C-3), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 125.5 (C-5′), 122.8 (C-6′), 120.67 (C-4′), 111.8 (C-3′), 56.15 (2′-OCH3), 42.85 (C-7′′); EIMS (m/z) 310 [M+], 281, 249, 207, 188, 160, 106, 91; HRMS (m/z): 310.1318 (calculated for C18H18N2O3, 310.1315).(2E)-N-Benzyl-
N
′
-(3-methoxyphenyl)but-2-enediamide(3c).
White powder (65% yield); mp 240-241°C; UV λmax (CH3OH) nm (log ε) 310 (3.88), 280 (3.88), 240 (4.04); IR (KBr) υmax (cm−1)  3266 (NH), 3070, 1633 (C=O), 1602 (NH), 1544, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 10.45 (s, 1H, NH-5), 9.02 (bt, 1H, J=5.8Hz, NH-6), 7.38 (s, 1H, H-2′), 7.33–7.35 (m, 2H, H-3′′/H-5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.19–7.23 (m, 2H, H-5′,6′), 7.08 (d, 1H, J=15.1Hz, H-2), 7.02 (d, 1H, J=15.1Hz, H-3), 6.69 (d, 1H,  J=7.8Hz, H-4′), 4.40 (d, 2H, J=5.8Hz, H-7′′), 3.73 (s, 3H, 3′-OCH3); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 162.7 (C-4), 160.0 (C-3′), 140.4 (C-1′), 139.3 (C-1′′), 134.2 (C-2), 133.7 (C-3), 130.1 (C-5′), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.5 (C-4′′), 112.2 (C-6′), 109.7 (C-4′), 105.7 (C-2′), 55.5 (3′-OCH3), 42.9 (C-7′′). EIMS (m/z): 310 [M+], 281, 207, 187, 176, 149, 106, 91; HRMS (m/z):  310.1315 (calculated for C18H18N2O3, 310.1315).(2E)-N-Benzyl-
N
′
-(2-chlorophenyl)but-2-enediamide(3d).
Pale brown powder (24% yield); mp 244-245°C; UV λmax (CH3OH) nm (log ε) 275 (4.36); IR (KBr) υmax (cm−1)  3267 (NH), 3032, 1626 (C=O), 1531, 1494; 1H NMR (DMSO-d6, 400 MHz) δ 10.08 (s, 1H, NH-5), 9.00 (bt, 1H, J=5.9Hz, NH-6), 7.79 (d, 1H, J=7.9Hz, H-6′),  7.53 (d, 1H,  J=7.9Hz, H-3′), 7.32–7.35 (m, 2H, H-3′′/5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.07 (d, 2H, J=15.2Hz, H-2/3), 4.42 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.0 (C-1), 163.1 (C-4), 139.3 (C-1′′), 134.9  (C-2), 134.8 (C-3), 133.1 (C-4′), 130.1 (C-3′), 128.9 (C-3′′/5′′), 127.9 (C-4′′), 127.8 (C-2′′/6′′), 127.4 (C-5′), 126.9 (C-6′), 42.9 (C-7′′); EIMS (m/z): 314 [M+], 281, 207, 187, 138, 106; HRMS (m/z):  314.0820 (calculated for C17H15ClN2O2, 314.0820).(2E)-N-Benzyl-
N
′
-(3-chlorophenyl)but-2-enediamide(3e).
Pink powder (30% yield); mp 272–274°C; UV λmax (CH3OH) nm (log ε) 290 (4.66), 240 (4.60); IR (KBr) υmax (cm−1) 3265 (NH), 3066, 1633 (C=O), 1592, 1541, 1482; 1H NMR (DMSO-d6, 400 MHz) δ 10.63 (s, 1H, NH-5), 9.03 (bt, 1H, J=5.9Hz, NH-6), 7.92 (s, 1H, H-2′), 7.51 (d, 1H,  J=8.5Hz, H-4′), 7.36–7.38 (m, 1H, H-5), 7.32–7.34 (m, 2H, H-3′′/5′′), 7.25–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.17 (d, 1H, J=8.5Hz, H-6′), 7.06 (s, 2H, H-2/3), 4.41 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.4 (C-1), 162.5 (C-4), 140.2 (C-1′), 138.8 (C-1′′), 134.2 (C-2), 133.1 (C-3), 132.7 (C-3′), 130.5 (C-5′), 128.4 (C-3′′/5′′), 127.3 (C-2′′/6′′), 126.9 (C-4′′),  123.5 (C-6′), 118.8 (C-2′), 117.8 (C-4′), 42.4 (C-7′′). EIMS (m/z) 314 [M+], 281, 207, 180, 153, 138, 117, 106, 91; HRMS (m/z):  314.0826 (calculated for C17H15ClN2O2,   314.0820).(2E)-N-Benzyl-
N
′
-(3-nitrophenyl)but-2-enediamide(3f).
Cream powder (29% yield); mp 259–261°C; UV λmax (CH3OH) nm (log ε) 275 (5.21); IR (KBr) υmax (cm−1) 3271 (NH), 3038, 1643 (C=O), 1621, 1529; 1H NMR (DMSO-d6, 400 MHz) δ 10.95 (s, 1H, NH-5), 9.07 (bt, 1H, J=5.3Hz, NH-6), 8.74 (s, 1H, H-2′), 7.97 (d, 2H, J=7.8Hz, H-4′/6′), 7.67 (t, 1H, J=7.8Hz, H-5′), 7.33–7.35 (m, 2H, H-3′′/5′′), 7.26–7.29 (m, 3H, H-2′′/6′′, H-4′′), 7.10 (s, 2H, H-2/3), 4.43 (d, 2H, J=5.3Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.8 (C-1), 163.4 (C-4), 148.5 (C-3′), 140.4 (C-1′), 139.3 (C-1′′), 135.0 (C-2), 133.0 (C-3), 130.8 (C-5′), 128.9 (C-3′′/5′′), 127.9 (C-2′′/6′′), 127.5 (C-4′′), 125.8 (C-6′), 118.9 (C-4′), 113.9 (C-2′), 42.9 (C-7′′). EIMS (m/z): 325 [M+], 280, 234, 191, 164, 149, 117, 91; HRMS (m/z):  325.1057 (calculated for C18H18N2O3, 325.1060).(2E)-N-Benzyl-
N
′
-(4-nitrophenyl)but-2-enediamide(3g).
Pale brown powder (12% yield); mp 274–276°C; UV λmax (CH3OH) nm (log ε) 325 (4.90); IR  (KBr) υmax (cm−1) 3267 (NH), 3062, 1626 (C=O), 1534, 1492; 1H NMR (DMSO-d6, 400 MHz) δ 11.05 (s, 1H, NH-5), 9.07 (bt, 1H, J=5.9Hz, NH-6), 8.26 (d, 2H, J=9.1Hz, H-3′′/5′′), 7.92 (d, 2H,  J=9.1Hz, H-2′′/6′′), 7.29–7.35 (m, 2H, H-3′′/5′′), 7.25–7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.11 (s, 2H, H-2,3), 4.42 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.6 (C-1), 163.3 (C-4), 145.2 (C-1′), 142.9 (C-4′), 139.0 (C-1′′), 135.2 (C-2), 132.7 (C-3), 128.6 (C-3′′/5′′), 127.7 (C-2′′/6′′), 127.3  (C-4′′), 125.3 (C-3′/5′), 119.5 (C-2′/6′), 42.8 (C-7′′); EIMS (m/z): 325, 281, 249, 207, 187, 167, 149, 106; HRMS (m/z):  325.1059 (calculated for C17H15N3O4, 325.1060).(2E)-N-Benzyl-
N
′
-(pyridin-3-yl)but-2-enediamide(3h).
Brown powder (27% yield); mp 198–200°C; UV λmax (CH3OH) nm (log ε) 270 (4.64), 240 (4.75); IR (KBr) υmax (cm−1) 3268 (NH), 3061, 1625 (C=O), 1532 (NH), 1493; 1H NMR (DMSO-d6, 600 MHz) δ 10.69 (s, 1H, NH-5), 9.04 (bt, 1H, J=5.6Hz, NH-6), 8.81 (s, 1H, H-2′), 8.31 (d, 1H, J=8.2Hz, H-6′), 8.14 (d, 1H, J=8.2Hz, H-4′), 7.38-7.39 (m, H-5′), 7.34–7.36 (m, 2H, H-3′′/5′′), 7.26–7.30 (m, 3H, H-2′′/6′′, H-4′′), 7.10 (d, 1H, J=15.1Hz, H-3), 7.07 (d, 1H, J=15.1Hz, H-2), 4.42 (d, 2H, J=5.6Hz, H-7′′); 13C NMR (DMSO-d6, 150 MHz) δ 163.9 (C-1), 163.2 (C-4), 145.2 (C-6′), 141.4 (C-2′), 139.3 (C-3′), 136.0 (C-1′′), 134.7 (C-2), 133.0 (C-3), 128.9 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.5 (C-4′′), 126.8 (C-4′), 124.2 (C-5′),  42.9 (C-7′′). EIMS (m/z) 281 [M+], 207, 187, 147, 119, 106, 91; a high resolution mass could not be detected for this compound despite several attempts.(2E)-N-Benzyl-
N
′
-(3-fluorobenzyl)but-2-enediamide(3j).
White powder (45% yield); mp 298–300°C; UV λmax (CH3OH) nm (log ε) 250 (4.08); IR (KBr) υmax (cm−1) 3275 (NH), 3085, 1626 (C=O), 1591, 1555; 1H NMR (DMSO-d6, 400 MHz) δ 8.94 (t, 1H, J=5.9Hz, NH-5), 8.93 (t, 1H, J=5.9Hz, NH-6), 7.30–7.36 (m, 3H, H-5′, H-3′′/5′′), 7.25–7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.05–7.11 (m, 3H, H-2′,4′,6′), 6.93 (s, 2H, H-2/3), 4.39 (d, 2H, J=5.9Hz, H-7′), 4.37 (d, 2H, J=5.9Hz, H-7′′); 13C NMR (DMSO-d6, 100 MHz) δ 163.8 (C-4), 163.6 (C-1), 162.2 (d, JCF=242.0Hz, C-3′), 141.9 (d, JCF=7.2Hz, C-1′), 138.9 (C-1′′), 132.9 (C-2), 132.6 (C-3),  130.3 (d, JCF=8.4Hz, C-5′), 128.3 (C-3′′/5′′), 127.3 (C-2′′/6′′), 126.9 (C-4′′), 123.2 (d, JCF=2.7Hz, C-6′),  113.9 (d, JCF=21.3Hz, C-2′), 113.6 (d, JCF=20.9Hz, C-4′), 42.3 (C-7′), 41.8 (C-7′′); 19F-NMR (DMSO-d6, 376.5 MHz) δ  −113.46, HRMS (m/z):  312.1270 (calculated for C18H17N2O2F, 312.1272).(2E)-N-Benzyl-
N
′
-(4-fluorobenzyl)but-2-enediamide(3k).
Pink powder (50% yield); mp 299–301°C; UV λmax (CH3OH) nm (log ε) 250 (4.50); IR (KBr) υmax (cm−1) 3275 (NH), 3084, 1624 (C=O), 1539, 1487; 1H NMR (DMSO-d6, 400 MHz) δ 8.97 (bs, 1H, NH-5), 8.93 (bs, 1H, NH-6), 7.36–7.38 (m, 2H, H-3′′/5′′), 7.31-7.32 (m, 2H, H-2′/6′), 7.26-7.27 (m, 3H, H-2′′/6′′, H-4′′), 7.09–7.11 (m, 2H, H-3′/5′), 6.93 (s, 2H, H-2/3), 4.38 (bs,  4H, H-7′/7′′); 13C NMR (DMSO-d6, 100 MHz) δ 164.2 (C-1), 164.1 (C-4), 161.6 (d, JCF=252.5Hz, C-4′), 139.4 (C-1′), 135.7 (C-1′′), 133.3 (C-2), 133.2 (C-3), 129.8 (d,  JCF=8.0Hz, C-2′/6′), 128.8 (C-3′′/5′′), 127.8 (C-2′′/6′′), 127.4 (C-4′′), 115.6  (d, JCF=20.9Hz, C-3′/5′), 42.8 (C-7′), 42.1 (C-7′′); 19F-NMR (DMSO-d6, 376.5 MHz) δ −116.0, HRMS (m/z): 312.1271 (calculated for C18H17FN2O2, 312.1272).


## 2.4. Biological Assay

Microbial Strains. The test compounds were evaluated on American Type Culture Collection (ATCC) strains of four Candida yeasts, Candida albicans (90028), Candida albicans (10231), Candida krusei (6258), and Candida parapsilosis (22019). Yeast strains were grown on sabouraud dextrose agar (SDA) and incubated at 35°C for 24 h.Antifungal Agents. The test compounds were dissolved in DMSO and made to a final concentration of 2% DMSO in each well.  All dilutions were done just prior to carrying out the assays. The final concentration of the test compounds ranged from 3.8 nM to 715.0 µM.  All drug dilutions were carried out in 96-well flat bottom microtitre plates. Amphotericin-B from Sigma Aldrich was used as a reference drug for the antifungal assay.Antifungal Susceptibility Test. Evaluation of the susceptibility of Candida albicans and non-Candida albicans species as performed using the broth microdilution method according to M27-A2 for yeast guidelines [31]. Yeast strains were grown aerobically overnight at 35°C on SDA plates. Yeasts were harvested and suspended in 1% sterile saline, and the turbidity of the supernatants measured spectrophotometrically at 625 nm with an absorbance of 0.08–0.1 is equivalent to a 0.5 McFarland standard following the NCCLS M27-A2 guidelines. The working suspension was diluted 20 times in a mixture containing RPMI 1640 medium and 0.165 M morpholinepropanesulfonic acid buffered to a pH of  7.0. The working suspension was further diluted 50 times to obtain the final test inoculums (1-5×103CFUmL-1). The microtitre plates that contained different concentrations of the test compounds were allowed to thaw and equilibrate to room temperature under aseptic conditions.  Aliquots of working inoculum suspensions were dispensed into each well, and the plates incubated in an aerobic environment at 35°C for 24 h. After incubation, 20 µL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS, Promega Corporation, Madison, USA) was added directly to  each well, incubated at 37°C for 4 h and the absorbance recorded at 490 nm on a 96-well plate reader (VACUTEC). All analyses were performed in triplicate, and data are reported as the mean ± standard error of the mean of ≤5.


## 3. Results and Discussion

### 3.1. Chemistry

Our synthetic route involved two steps (Scheme1). The first was the formation of the acid by nucleophilic addition of the amine to maleic anhydride.  The reaction takes place in toluene under reflux conditions, where the amine attacks the carbonyl carbon of maleic anhydride, which breaks open forming the first amide bond and the carboxylic acids (intermediates 2a–k). The second step occurs via a Steglich esterification, in which diisopropylcarbodiimide (DIC) is used as a coupling reagent and dimethylaminopyridine (DMAP) as a catalyst [24].Scheme 1
Preparation of butenediamide analogues.The reaction involves abstraction of a proton from the acid by DMAP.  The carboxylate ion that forms attacks the DIC to form theO-acylisourea which is more reactive toward nucleophilic substitution than the acid. The amine now attacks this O-acylisourea to form the diamide with diisopropylurea (DIU) as an unwanted by-product, which complicates the purification and diminishes the yield of the final product.The reaction takes place at room temperature for at least 12 h under nitrogen gas. With dichloromethane (DCM) alone, an insoluble DIU was formed as a solid by-product. The product yield obtained after filtration of the DIU for this step of the reaction was unsatisfactory at between 2–20%. Changing the solvent to DMF in subsequent reactions improved the yields for this step considerably by approximately 10% on average, and in some cases stepwise yields of between 50% and 85% were achieved. The overall yields are given in the experimental section and ranged between 12% and 65%. For the phenylamino derivatives3a–3g, electron donating substituents at the 2′-position resulted in low overall yields, 18% (3b) and 24% (3d) compared to the same substituents at the 3′-position, 65% (3c) and 30% (3e). Electron withdrawing substituents, such as the nitro group, at the 3′-position are better for benzylamine coupling with the carboxyl group than the same substitution at the 4′-position, 29% for 3f compared to 12% (3g). Substituting electron donating substituents at the 2′-position makes the carboxyl carbon less electrophilic to substitution with the benzylamine as does electron withdrawing substituents at the 4′-position. The pyridin-3-yl and the fluorobenzylamino derivatives had acceptable overall yields of 27% (3h), 32% (3i), 45% (3j), and 50% (3k). Since the DIU by-product was completely soluble in DMF, DCM is needed to extract the organic product.   The remaining DIU is removed by washing with water, and the pure products (3a–k) precipitated out of the DCM fraction upon cooling.The structures of the molecules were confirmed by1H and 13C NMR spectroscopy and by 2D correlation (HSQC and HMBC). For example, the 1H NMR spectrum of 3a shows a pair of doublets at δH 7.11 (H-3, J=15.1Hz) and δH 7.04 (H-2, J=15.1Hz), the large coupling constant indicating trans olefinic methine groups. The H-3 resonance was assigned further downfield than the H-2 resonance, since this resonance is seen to shift downfield when a methoxy group is present at the 2′-position. For example, H-3 in 3a is at δH 7.11, while H-3 in 3b is at δH 7.35. The H-2 resonance does not shift and appears at approximately δH 7.01. These resonances also show HMBC correlations to both the carbonyl amide resonances at δC 164.0 (C-1) and δC 162.7 (C-4). The C-1 carbonyl resonance occurs more downfield than the C-4 carbonyl resonance. In 3a, there is no HMBC correlation to prove this; however, in the 2′-methoxy derivative (3b), a distinct correlation can be seen between the NH-6 triplet and the C-1 carbonyl resonance.  The NH-6 triplet in 3a appears at δH 9.01, and the NH-5 resonance appears at δH 10.47 as a singlet resonance.  These resonances and 2D correlations confirm the but-2-enediamide moiety.The H-7′′ benzyl methylene resonance was critical in assigning the aromatic proton resonances and distinguishing the resonances of the two aromatic rings.  The H-7′′ resonance atδH 4.41 showed HMBC correlations to both the C-1′′ and C-2′′/6′′ resonances at δC 139.4 and δC 127.8.  The other singlet aromatic carbon resonance at δC 139.3 was then assigned to C-1′ on the other aromatic ring, which allowed H-3′/5′ to be assigned since a correlation between C-1′ and H-3′/5′ was seen in the HMBC spectrum. The H-2′/6′ proton resonance was distinctly shifted more downfield by the anisotropic effect of the amide group and appeared at δH 7.68 as a doublet with J=8.1Hz.  This resonance showed an HMBC correlation to C-4′ at δC 124.3.  The H-3′′/5′′ resonance overlapped with the H-3′/5′ resonance at δH 7.34–7.36 as a multiplet, and the remaining H-4′′ resonance was then assigned together with the H-2′′/6′′ resonance as the multiplet at δH 7.28–7.33.  Using the HSQC spectrum to identify the corresponding proton and carbon resonances, all the resonances could be identified. The resonances of the other compounds were determined in a similar fashion.


### 3.2.  Biological Results

The synthesised compounds were tested against two strains ofCandida albicans (ATCC90028 and ATCC10231) as well as Candida krusei (ATCC6258) and Candida parapsilosis (ATCC22019). Compounds 3a and 3c had the best activity from all the compounds tested against (Table 1).  These were the compounds with an unsubstituted phenyl ring (3a) and the 3′-methoxysubstituted derivative (3c). Compound 3d with a 2′-chlorosubstituent and 3i with two benzyl groups attached to the butanediamine also had moderate activity against the four strains of fungi. Moderate strain specific activity against C. krusei and C. parapsilosis was also seen by 3e with a 3′-chloro group; however, C. albicans was totally resistant to this compound.  Of the four strains, C. krusei was the most resistant to compounds 3a and 3c, the most active compounds. The benzyl pyridin-3-ylbut-2-enediamide (3h), although susceptible to C. albicans and C. parapsilosis, showed moderate activity against C. krusei and 3g, the 4′-nitro compound showed moderate activity against C. parapsilosis.Table 1
Antifungal activity of the synthesised butenediamides (MIC)μM.
Compound
C. albicans (ATCC90028)
C. albicans (ATCC10231)
C. krusei (ATCC6258)
C. parapsilosis (ATCC22019)
3a
44.6 ± 0.57
44.6 ± 1.21
178.5 ± 0.36
44.6 ± 0.46
3b
—
—
—
—
3c
40.3 ± 0.48
80.6 ± 0.42
161.2 ± 1.61
20.2 ± 0.39
3d
159.2 ± 0.45
159.2 ± 0.60
159.2 ± 0.51
159.2 ± 0.41
3e
636.8 ± 0.64
636.8 ± 2.55
159.2 ± 0.80
159.2 ± 1.43
3f
—
—
615.2 ± 0.65
615.2 ± 1.54
3g
307.6 ± 0.31
307.6 ± 0.77
307.6 ± 0.40
153.8 ± 2.21
3h
355.7 ± 1.78
355.7 ± 0.75
177.9 ± 0.60
355.7 ± 0.89
3i
170.0 ± 0.44
170.0 ± 0.41
170.0 ± 1.16
170.0 ± 0.61
3j
320.4 ± 0.54
320.4 ± 0.51
640.8 ± 1.60
640.8 ± 1.60
3k
640.8 ± 1.12
640.8 ± 0.80
640.8 ± 0.74
640.8 ± 0.51
Amphotericin-B
1.3 ± 0.60
1.3 ± 0.49
5.4 ± 0.54
1.3 ± 0.27
All experiments were carried out in triplicate. Data reported as the mean of three experiments.
Key:  —: No activity.In general, the positions of the methoxy- and chlorosubstituents on the phenyl ring were important as the activity of the methoxygroup was associated with the 3′-position only, and the 2′-chlorocompound (3d) showed better activity than the 3′-chlorocompound against C. albicans. Compound 3b, the 3-methoxy derivative, was completely susceptible to all the fungal strains as were the fluorosubstituted benzyl derivatives (3j and 3k) and the 3-nitrophenyl derivative (3f).


## 3.1. Chemistry

Our synthetic route involved two steps (Scheme1). The first was the formation of the acid by nucleophilic addition of the amine to maleic anhydride.  The reaction takes place in toluene under reflux conditions, where the amine attacks the carbonyl carbon of maleic anhydride, which breaks open forming the first amide bond and the carboxylic acids (intermediates 2a–k). The second step occurs via a Steglich esterification, in which diisopropylcarbodiimide (DIC) is used as a coupling reagent and dimethylaminopyridine (DMAP) as a catalyst [24].Scheme 1
Preparation of butenediamide analogues.The reaction involves abstraction of a proton from the acid by DMAP.  The carboxylate ion that forms attacks the DIC to form theO-acylisourea which is more reactive toward nucleophilic substitution than the acid. The amine now attacks this O-acylisourea to form the diamide with diisopropylurea (DIU) as an unwanted by-product, which complicates the purification and diminishes the yield of the final product.The reaction takes place at room temperature for at least 12 h under nitrogen gas. With dichloromethane (DCM) alone, an insoluble DIU was formed as a solid by-product. The product yield obtained after filtration of the DIU for this step of the reaction was unsatisfactory at between 2–20%. Changing the solvent to DMF in subsequent reactions improved the yields for this step considerably by approximately 10% on average, and in some cases stepwise yields of between 50% and 85% were achieved. The overall yields are given in the experimental section and ranged between 12% and 65%. For the phenylamino derivatives3a–3g, electron donating substituents at the 2′-position resulted in low overall yields, 18% (3b) and 24% (3d) compared to the same substituents at the 3′-position, 65% (3c) and 30% (3e). Electron withdrawing substituents, such as the nitro group, at the 3′-position are better for benzylamine coupling with the carboxyl group than the same substitution at the 4′-position, 29% for 3f compared to 12% (3g). Substituting electron donating substituents at the 2′-position makes the carboxyl carbon less electrophilic to substitution with the benzylamine as does electron withdrawing substituents at the 4′-position. The pyridin-3-yl and the fluorobenzylamino derivatives had acceptable overall yields of 27% (3h), 32% (3i), 45% (3j), and 50% (3k). Since the DIU by-product was completely soluble in DMF, DCM is needed to extract the organic product.   The remaining DIU is removed by washing with water, and the pure products (3a–k) precipitated out of the DCM fraction upon cooling.The structures of the molecules were confirmed by1H and 13C NMR spectroscopy and by 2D correlation (HSQC and HMBC). For example, the 1H NMR spectrum of 3a shows a pair of doublets at δH 7.11 (H-3, J=15.1Hz) and δH 7.04 (H-2, J=15.1Hz), the large coupling constant indicating trans olefinic methine groups. The H-3 resonance was assigned further downfield than the H-2 resonance, since this resonance is seen to shift downfield when a methoxy group is present at the 2′-position. For example, H-3 in 3a is at δH 7.11, while H-3 in 3b is at δH 7.35. The H-2 resonance does not shift and appears at approximately δH 7.01. These resonances also show HMBC correlations to both the carbonyl amide resonances at δC 164.0 (C-1) and δC 162.7 (C-4). The C-1 carbonyl resonance occurs more downfield than the C-4 carbonyl resonance. In 3a, there is no HMBC correlation to prove this; however, in the 2′-methoxy derivative (3b), a distinct correlation can be seen between the NH-6 triplet and the C-1 carbonyl resonance.  The NH-6 triplet in 3a appears at δH 9.01, and the NH-5 resonance appears at δH 10.47 as a singlet resonance.  These resonances and 2D correlations confirm the but-2-enediamide moiety.The H-7′′ benzyl methylene resonance was critical in assigning the aromatic proton resonances and distinguishing the resonances of the two aromatic rings.  The H-7′′ resonance atδH 4.41 showed HMBC correlations to both the C-1′′ and C-2′′/6′′ resonances at δC 139.4 and δC 127.8.  The other singlet aromatic carbon resonance at δC 139.3 was then assigned to C-1′ on the other aromatic ring, which allowed H-3′/5′ to be assigned since a correlation between C-1′ and H-3′/5′ was seen in the HMBC spectrum. The H-2′/6′ proton resonance was distinctly shifted more downfield by the anisotropic effect of the amide group and appeared at δH 7.68 as a doublet with J=8.1Hz.  This resonance showed an HMBC correlation to C-4′ at δC 124.3.  The H-3′′/5′′ resonance overlapped with the H-3′/5′ resonance at δH 7.34–7.36 as a multiplet, and the remaining H-4′′ resonance was then assigned together with the H-2′′/6′′ resonance as the multiplet at δH 7.28–7.33.  Using the HSQC spectrum to identify the corresponding proton and carbon resonances, all the resonances could be identified. The resonances of the other compounds were determined in a similar fashion.


## 3.2.  Biological Results

The synthesised compounds were tested against two strains ofCandida albicans (ATCC90028 and ATCC10231) as well as Candida krusei (ATCC6258) and Candida parapsilosis (ATCC22019). Compounds 3a and 3c had the best activity from all the compounds tested against (Table 1).  These were the compounds with an unsubstituted phenyl ring (3a) and the 3′-methoxysubstituted derivative (3c). Compound 3d with a 2′-chlorosubstituent and 3i with two benzyl groups attached to the butanediamine also had moderate activity against the four strains of fungi. Moderate strain specific activity against C. krusei and C. parapsilosis was also seen by 3e with a 3′-chloro group; however, C. albicans was totally resistant to this compound.  Of the four strains, C. krusei was the most resistant to compounds 3a and 3c, the most active compounds. The benzyl pyridin-3-ylbut-2-enediamide (3h), although susceptible to C. albicans and C. parapsilosis, showed moderate activity against C. krusei and 3g, the 4′-nitro compound showed moderate activity against C. parapsilosis.Table 1
Antifungal activity of the synthesised butenediamides (MIC)μM.
Compound
C. albicans (ATCC90028)
C. albicans (ATCC10231)
C. krusei (ATCC6258)
C. parapsilosis (ATCC22019)
3a
44.6 ± 0.57
44.6 ± 1.21
178.5 ± 0.36
44.6 ± 0.46
3b
—
—
—
—
3c
40.3 ± 0.48
80.6 ± 0.42
161.2 ± 1.61
20.2 ± 0.39
3d
159.2 ± 0.45
159.2 ± 0.60
159.2 ± 0.51
159.2 ± 0.41
3e
636.8 ± 0.64
636.8 ± 2.55
159.2 ± 0.80
159.2 ± 1.43
3f
—
—
615.2 ± 0.65
615.2 ± 1.54
3g
307.6 ± 0.31
307.6 ± 0.77
307.6 ± 0.40
153.8 ± 2.21
3h
355.7 ± 1.78
355.7 ± 0.75
177.9 ± 0.60
355.7 ± 0.89
3i
170.0 ± 0.44
170.0 ± 0.41
170.0 ± 1.16
170.0 ± 0.61
3j
320.4 ± 0.54
320.4 ± 0.51
640.8 ± 1.60
640.8 ± 1.60
3k
640.8 ± 1.12
640.8 ± 0.80
640.8 ± 0.74
640.8 ± 0.51
Amphotericin-B
1.3 ± 0.60
1.3 ± 0.49
5.4 ± 0.54
1.3 ± 0.27
All experiments were carried out in triplicate. Data reported as the mean of three experiments.
Key:  —: No activity.In general, the positions of the methoxy- and chlorosubstituents on the phenyl ring were important as the activity of the methoxygroup was associated with the 3′-position only, and the 2′-chlorocompound (3d) showed better activity than the 3′-chlorocompound against C. albicans. Compound 3b, the 3-methoxy derivative, was completely susceptible to all the fungal strains as were the fluorosubstituted benzyl derivatives (3j and 3k) and the 3-nitrophenyl derivative (3f).


## 4. Conclusion

The substituted aromatic but-2-enediamides were successfully synthesised and their structures confirmed by NMR spectroscopy. In general, the (2E)-N-benzyl-N′-phenylbut-2-enediamide class showed better antifungal ability than the (2E)-N-N′-dibenzylbut-2-enediamide series which showed lower antifungal activity. Even though these compounds were not as active as the standard drug Amphotericin B, the compounds may be useful in situations where resistance is built up to currently used antifungal drugs.  Compounds 3a and 3c can definitely be explored for their potential to act as antifungal agents.



---

*Source: 281341-2013-06-02.xml*